Cystic Fibrosis Foundation Therapeutics announces $58 million CF drug discovery agreement with Pfizer
19 November 2012 | By Cystic Fibrosis Foundation
CFFT announced a major expansion of its research collaboration with Pfizer...
List view / Grid view
News
FDA approves new indication for PROMACTA® (eltrombopag)
19 November 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the U.S. FDA has approved PROMACTA for the treatment of thrombocytopenia...
Pfizer reports top-line results of a Phase 3 study evaluating pregabalin controlled-release as treatment for patients with fibromyalgia
19 November 2012 | By Pfizer
Top-line results of a Phase 3 study...
Roche study showed that Avastin helped people with newly diagnosed glioblastoma live longer without their disease worsening
17 November 2012 | By Roche
Results from positive phase III AVAglio study...
A LoGiCal® solution for forensic toxicology
16 November 2012 | By kdm communications limited
LGC Standards’ LoGiCal® reference materials are proving a valuable resource for scientists at the Institute of Forensic Research...
ZALTRAP® receives CHMP positive opinion in the European Union for previously treated mCRC
16 November 2012 | By Sanofi
“We are pleased that CHMP has supported our ZALTRAP application..."
Sanofi receives positive CHMP opinion in the European Union for once-daily Lyxumia® (lixisenatide)
16 November 2012 | By Sanofi
“The CHMP positive opinion for Lyxumia marks an important milestone..."
Novartis drug Exjade® recommended by CHMP for EU approval
16 November 2012 | By Novartis
The CHMP of the EMA adopted a positive opinion for Exjade®...
GlaxoSmithKline’s Synflorix is highly effective at preventing invasive pneumococcal disease
16 November 2012 | By GlaxoSmithKline
Results from the first randomised controlled European clinical trial...
Novartis receives positive CHMP opinion for Bexsero®
16 November 2012 | By Novartis
The CHMP of the EMA has adopted a positive opinion for Bexsero for use in individuals from 2 months of age and older...
Pfizer reports top-line results of a Phase 3 study evaluating pregabalin controlled-release formulation as adjunctive treatment in adult patients with partial onset seizures
16 November 2012 | By Pfizer
Pfizer Inc., announced top-line results of a double-blind, placebo-controlled, Phase 3 study...
Roche receives positive opinion from EMA for Avastin based treatment beyond first progression in people with advanced colorectal cancer
16 November 2012 | By Roche
The continued use of Avastin based therapy beyond first progression in metastatic colorectal cancer patients leads to survival benefits...
Strathclyde awards honorary degree to world-leading cancer researcher
15 November 2012 | By University of Strathclyde
A Nobel Prize winner has been awarded an honorary degree by the University of Strathclyde...
Tecan and Promega offer variable volume DNA isolation
15 November 2012 | By kdm communications limited
Tecan and Promega have developed a turnkey workstation for fully automated extraction of gDNA from whole blood samples...
Gilead ’s Complera® non-inferior to Atripla® among treatment-naïve HIV patients
15 November 2012 | By Gilead Sciences
STaR study findings support Complera as an important single tablet regimen option...
